rag & bone Looks to the Future with Appointment of Stefanie Strack as Chief Executive Officer
rag & bone announces today that Stefanie Strack has been named as its Chief Executive Officer.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180808005432/en/
rag & bone Announces Stefanie Strack As CEO (Photo: Business Wire)
Stefanie Strack’s appointment will become effective September 10th, 2018, at which time she will also be appointed to the rag & bone Board of Directors. Marcus Wainwright, the current CEO will assume a new title as Founder & Chief Brand Officer.
“I am beyond thrilled that Stefanie will be joining the company and I see her as a true partner. Stefanie brings us a wealth of experience in key strategic areas and personifies the rag & bone woman. Her coming on board allows me to focus on what I love, which is designing great product and continuing to build the rag & bone brand. Rag & bone has always challenged the status quo, always trying new ways of doing things. I know that Stefanie will continue that tradition of challenge and innovation leading us to an awesome future as a brand with a purpose and a singular focus on the customer.”
Marcus Wainwright, rag & bone Founder & Chief Brand Officer
Strack brings fresh perspective, energy, and strong leadership to rag & bone where she will focus on digital transformation and deepening the consumer connection globally across wholesale and direct-to-consumer. As an advocate for a more elevated, connected consumer experience, she will challenge the traditional product cycle and ignite the brand to become more personalized and responsive. Strack’s leadership style is uniquely suited to cultivate an inclusive and purpose-driven brand, which remains true to rag & bone’s focus on originality, quality and authenticity.
“As a professional, I have been inspired by rag & bone for years, and as a customer the brand has held a unique place in my heart. Authenticity is the essence of rag & bone, and I see that reflected throughout the rag & bone team. I am excited to be a part of this incredible culture, one that has purpose, passion and inspiration. We will create a brilliant future for those inside our company and those we serve.”
Stefanie Strack, rag & bone Chief Executive Officer
Strack has spent the last 14 years at Nike Inc., in a variety of operational and business roles, and has been an integral part of the Nike’s Corporate Leadership Team. Most recently, she held the position of Vice President/General Manager of Nike Express Lane, leading a global effort to meet evolving consumer needs with improved speed to market. Strack’s vision led to the development of a new division within Nike tasked with transforming all key direct-to-consumer functions: consumer sensing, data and analytics, design, supply chain and manufacturing. As noted in Nike’s earnings for the fourth quarter of fiscal 2018, Express Lane has created substantial impact and is now the fastest-growing product engine, serving as a key focal point of Nike’s speed initiative.
Prior to leading Nike Express Lane, Strack served as the General Manager of Nike Skateboarding. In that role, she focused on harnessing the passion of young millennials while bringing digital innovations to both the direct and wholesale marketplace. Strack now looks forward to bringing these rich insights and her multi-functional expertise home to rag & bone.
Through her culture-first, inclusive approach, Strack has become an innovative thought leader in the footwear and apparel industry and her extensive experience in leading, innovating and scaling visionary initiatives, will guide the evolution of rag & bone.
Her arrival comes as rag & bone prepares to accelerate its direct-to-consumer efforts. Having already become known as an industry disruptor, this appointment signals the next evolution in a brand consistently recognized for its uniquely individualistic and innovative approach.
About rag & bone:
Since its origins in New York in 2002, rag & bone has established itself as a critical and commercial success in the international fashion world. Combining English heritage with directional design, the brand has become synonymous with innately wearable clothing that has an edgy yet understated New York aesthetic.
rag & bone offers a full range of men’s and women’s ready to wear, denim, accessories and footwear collections. rag & bone operates 42 stores worldwide and also available in boutiques and department stores in over 53 countries. www.rag-bone.com
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
AURAK Gains SACSCOC Accreditation15.12.2018 13:49 | Tiedote
The Southern Association of Colleges and Schools Commission on Colleges (SACSCOC) officially announced the accreditation of the American University of Ras Al Khaimah (AURAK) at its 2018 Annual Meeting which was held in New Orleans, Louisiana, in the United States of America. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181215005017/en/ AURAK delegation during the SACSCOC conference in New Orleans” (Photo: AETOSWire) SACSCOC, the regional body for the accreditation of degree-granting higher education institutions in the Southern United States, has a membership of more than 800 institutions in the Southern states and other international sites approved by SACSCOC that award associate, baccalaureate, master’s, and/or doctoral degrees. SACSCOC also awards accreditation to other international institutions of higher education that satisfy all its requirements and demonstrate compliance with its accreditation standards. AURAK now
Lehman Brothers Treasury Announces Plans for Partial Wind-Down14.12.2018 20:41 | Tiedote
Lehman Brothers Treasury Co. B.V. in liquidation (“LBT”) today, through its U.S. counsel Kramer Levin Naftalis & Frankel LLP, announced that LBT is planning a final cash distribution to its creditors. Professional holders of eligible notes will have the option to retain their investment by electing to receive substitute notes of one (or a few) series. Such election shall take place through a solicitation process. As a consequence, LBT will be able to reduce the number of series of notes outstanding from more than 3,700 to one or a few. Noteholders electing to receive substitute notes will be afforded the same economic entitlement to distributions received by LBT from Lehman Brothers Holdings Inc. (“LBHI”) through the substitute notes. The substitute notes will be denominated in U.S. dollars and future distributions will be made in U.S. dollars only. Noteholders who are not professional investors, or hold notes that are not eligible for substitution, or do not elect to receive substitut
Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Combination with AVD14.12.2018 20:00 | Tiedote
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for the extension of the marketing authorization of ADCETRIS (brentuximab vedotin) and recommended its approval in combination with AVD in adult patients with previously untreated CD30+ Stage IV Hodgkin lymphoma. ADCETRIS is an antibody-drug conjugate (ADC) directed at CD30, a defining marker of Hodgkin lymphoma. ADCETRIS is currently not approved as a therapy for previously untreated Hodgkin lymphoma in Europe. “For a large number of previously untreated Hodgkin lymphoma patients diagnosed with Stage IV disease, progression will occur with current treatments, highlighting a true unmet need in this population,” said Anna Sureda, M.D., Ph.D., Head of the Hematology Department and Hematopoietic Stem Cell Transplant Programme, Institut Català d'Oncologia - Hospital Duran i Reynals. “In the ECHELON-1 cl
Diamond CBD, POTN Subsidiary, Enters the $46 Billion Coffee Market With the Release of Premium Line of CBD-Infused Coffee & Tea K-Kup Capsules14.12.2018 18:42 | Tiedote
Diamond CBD Inc., wholly owned subsidiary of PotNetwork Holdings, Inc. (OTC Pink: POTN), a leader in hemp extraction and innovative CBD products for the wellness market, enters the Coffee segment, an industry expected to reach revenues of $46 Billion in 2018. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181214005308/en/ Experience a cup of Chill (Photo: Business Wire) Produced in accordance with a universal K-Cup design, these pods fit in almost all modern single cup coffee makers, making it an easily integrated enhancement to any environment, delivering 25mgs of CBD in a tasty favorite beverage at less than $5 per cup. This new line of premium Chill Coffee Capsules was recently added to the Company’s broad range of cannabinoid and natural hemp products. Each box comes with 4 individual capsules in original chill coffee, decaf chill coffee, chill black tea, and chill green tea flavors. The unit price for each box is $10.00
Henley & Partners Enlarges Executive Committee to Manage Expansion and Growth14.12.2018 17:00 | Tiedote
Residence- and citizenship-by-investment programs have firmly established themselves over the past few years as the new frontier in terms of freedom, flexibility, and future-readiness, both for the countries issuing these programs and for the individual investors participating in them. The societal and economic value these programs generate is undisputed. The investment migration industry as a whole is currently grossing roughly USD 18 billion per year, with an expectation that it will hit the USD 20 billion mark very soon. Foreign direct investment (FDI) is now considered the lifeblood of economic growth for many developing and recovering smaller countries around the world. As such, the number of investment migration programs has been increasing rapidly, from just a handful of programs in the 1980s and 1990s to over 100 countries that now have investment migration provisions in their laws. There are more than 60 active programs today, with Moldova and Montenegro — both fast-growing Eu
Vargatef® plus docetaxel could be an option after failure of immunotherapy in lung cancer14.12.2018 12:07 | Tiedote
Boehringer Ingelheim announced today the first interim results of VARGADO, an ongoing non-interventional study in routine clinical practice in Germany evaluating the efficacy and safety of Vargatef® (nintedanib) and docetaxel in patients with stage III/IV locally advanced or metastatic non-small cell lung cancer (NSCLC) of adenocarcinoma histology. The study consists of three cohorts, two of which allow for prior treatment with immune checkpoint inhibitors (ICIs) either in combination with chemotherapy in the first-line or as monotherapy in the second-line of treatment. The interim results from Cohort B (first-line chemotherapy, second-line immune checkpoint inhibitors, third-line Vargatef® plus docetaxel) were presented today at ESMO Immuno-Oncology Congress 2018 in Geneva.1 Despite a limited sample size, the VARGADO study adds to the body of evidence for nintedanib in lung adenocarcinoma following pre-treatment with chemotherapy and ICIs.1,3 The addition of nintedanib to docetaxel ha
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme